Additionally, regular screenings for Barrett esophagus in high-risk individuals can aid in early detection and treatment, improving survival rates. Disclaimer: This article, including health and ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that by 2040, there will be approximately 957,000 new cases of esophageal cancer ...

A focused team of specialists at the Esophageal Cancer Center works in concert to create an individualized treatment plan upfront, so that the right combination and sequence of therapies can be ...

A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...

Driven by obesity and acid reflux, esophageal cancer has become the fastest rising cancer in Caucasian men in the United States. The thoracic oncologists and gastroenterologists at the Baylor St. Luke ...

Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...

Fight against cancer starts with understanding that knowledge is not just empowering but a survival tool. This holds for ...

The FDA has approved Tislelizumab (Tevimbra) plus platinum-based chemotherapy as a first-line treatment for adult patients with unresectable or metastatic esophageal squamous cell carcinoma whose ...

According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...

Medically reviewed by Qin Rao, MD Barrett's esophagus occurs when the lining of the esophagus, the tube that runs from the ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.